These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32809890)

  • 1. Efficacy and Safety of Corticosteroid Implants in Non-infectious Uveitis: A Systematic Review with Network Meta-analysis.
    Vieira R; Sousa-Pinto B; Figueira L
    Ocul Immunol Inflamm; 2022 Jan; 30(1):215-222. PubMed ID: 32809890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
    Arcinue CA; Cerón OM; Foster CS
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the Fluocinolone Acetonide (Yutiq) Intravitreal Implant as Monotherapy for Uveitis.
    Mahmud H; Ahmad TR; Gonzales JA; Stewart JM
    Ocul Immunol Inflamm; 2023 Oct; 31(8):1603-1607. PubMed ID: 35793136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Institution Experience of Intravitreal 0.18-mg Fluocinolone Acetonide Implant for Noninfectious Uveitis.
    Reddy AK; Pecen PE; Patnaik JL; Palestine AG
    Ophthalmol Retina; 2023 Jan; 7(1):67-71. PubMed ID: 35820567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis.
    Mruthyunjaya P; Khalatbari D; Yang P; Stinnett S; Tano R; Ashton P; Guo H; Nazzaro M; Jaffe GJ
    Arch Ophthalmol; 2006 Jul; 124(7):1012-8. PubMed ID: 16832025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis.
    ; Kempen JH; Altaweel MM; Holbrook JT; Sugar EA; Thorne JE; Jabs DA
    JAMA; 2017 May; 317(19):1993-2005. PubMed ID: 28477440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
    Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
    Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.
    Jaffe GJ; Ben-Nun J; Guo H; Dunn JP; Ashton P
    Ophthalmology; 2000 Nov; 107(11):2024-33. PubMed ID: 11054326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluocinolone acetonide ophthalmic--Bausch & Lomb: fluocinolone acetonide Envision TD implant.
    Drugs R D; 2005; 6(2):116-9. PubMed ID: 15777105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Pouwels XGLV; Petersohn S; Carrera VH; Denniston AK; Chalker A; Raatz H; Armstrong N; Shah D; Witlox W; Worthy G; Noake C; Riemsma R; Kleijnen J; Joore MA
    Pharmacoeconomics; 2020 May; 38(5):431-441. PubMed ID: 31701471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the Dexamethasone Implant in Lieu of Oral Corticosteroids in Intermediate and Posterior Uveitis Requiring Immunosuppression.
    Berkenstock MK; Mir TA; Khan IR; Burkholder BM; Chaon BC; Shifera AS; Thorne JE
    Ocul Immunol Inflamm; 2022 Apr; 30(3):741-749. PubMed ID: 33021854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults.
    Squires H; Poku E; Bermejo I; Cooper K; Stevens J; Hamilton J; Wong R; Denniston A; Pearce I; Quhill F
    Health Technol Assess; 2017 Nov; 21(68):1-170. PubMed ID: 29183563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone for ocular inflammation.
    Saraiya NV; Goldstein DA
    Expert Opin Pharmacother; 2011 May; 12(7):1127-31. PubMed ID: 21457057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evaluation of YUTIQ™ (fluocinolone acetonide intravitreal implant 0.18 mg) in posterior uveitis.
    Testi I; Pavesio C
    Ther Deliv; 2019 Oct; 10(10):621-625. PubMed ID: 31663454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
    Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA
    JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.
    Pavesio C; Zierhut M; Bairi K; Comstock TL; Usner DW;
    Ophthalmology; 2010 Mar; 117(3):567-75, 575.e1. PubMed ID: 20079922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retisert: is the new advance in treatment of uveitis a good one?
    Mohammad DA; Sweet BV; Elner SG
    Ann Pharmacother; 2007 Mar; 41(3):449-54. PubMed ID: 17341531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
    ; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
    Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial.
    Sen HN; Abreu FM; Louis TA; Sugar EA; Altaweel MM; Elner SG; Holbrook JT; Jabs DA; Kim RY; Kempen JH;
    Ophthalmology; 2016 Jan; 123(1):183-90. PubMed ID: 26499920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results.
    Jaffe GJ; Foster CS; Pavesio CE; Paggiarino DA; Riedel GE
    Ophthalmology; 2019 Apr; 126(4):601-610. PubMed ID: 30367884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.